{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-029107","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2025-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.841403+00:00","generated_at":"2026-05-16T12:18:45.421656+00:00","sec_items":["1.01","3.02","3.03","5.03","5.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Indaptus raises $6M via convertible preferred; Lazar appointed Chairman and Co-CEO","bullets":["David Lazar invests $6M for 300K Series AA and 700K Series AAA shares convertible into 111M common shares after stockholder approval.","Lazar appointed Chairman and Co-CEO; board adds Avraham Ben-Tzvi; directors Martell and Karah resign.","Special meeting by Mar 31, 2026 to approve conversion, authorized share increase, written consent, reverse split, and Lazar board nominees.","Executive officers modify employment: reduce notice to 10 days, waive severance for stock/cash; CMO Waltzman resigns with $207K bonus.","Issuance under Regulation S exemption; proceeds for operations, severance, working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-029107","json":"https://secwatch.observer/filing/0001493152-25-029107.json","markdown":"https://secwatch.observer/filing/0001493152-25-029107.md","text":"https://secwatch.observer/filing/0001493152-25-029107.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000149315225029107/0001493152-25-029107-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000149315225029107/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:18:45.421656+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}